Concepts regarding formation, action, and pharmacologic inhibition of arachidonic acid metabolites in asthma

The Journal of Asthma : Official Journal of the Association for the Care of Asthma
H G Morris

Abstract

Lipid products derived from the metabolism of arachidonic acid have a central role in inflammatory reactions and probably contribute to the pathophysiology of bronchial asthma as well as other obstructive diseases of the lung. Metabolites of arachidonic acid also modulate numerous physiologic responses. The goal of pharmacologic intervention is to enhance the beneficial effects of certain arachidonate metabolites and to inhibit those which are undesirable. Development of new pharmacologic agents which selectively inhibit synthesis or action of certain arachidonic acid metabolites, particularly the bronchospastic leukotrienes, may provide more effective treatment of asthma in the future.

References

Jan 1, 1979·The Journal of Allergy and Clinical Immunology·C W Parker
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·S E DahlénB Samuelsson
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J M DrazenE J Corey

❮ Previous
Next ❯

Citations

Jan 1, 1983·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·C J Falliers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.